DOI: 10.1055/s-00000021

Gesundheitsökonomie & Qualitätsmanagement

References

Ruof J, Scherer J, Schulenburg JM.
Appropriate comparative treatments for early benefit assessment (EBA) in Germany. Comparing the suggestions of the Joint Federal Committee (GBA) and the pharmaceutical companies. Abstract PRM 162; ISPOR 15th Annual European Congress, 3–7 November 2012, Berlin, Germany.

Value Health 2012;
15 (07) A 490

Download Bibliographical Data

Search in: